Mahajan Anubha, Tabassum Rubina, Chavali Sreenivas, Dwivedi Om Prakash, Bharadwaj Mausumi, Tandon Nikhil, Bharadwaj Dwaipayan
Functional Genomics Unit, Institute of Genomics and Integrative Biology, Delhi 110 007, India.
J Clin Endocrinol Metab. 2009 Jun;94(6):2123-7. doi: 10.1210/jc.2008-2754. Epub 2009 Mar 31.
Elevated high-sensitivity C-reactive protein (hsCRP) levels have frequently been shown to be associated with type 2 diabetes (T2D); however, very little is known about this in Asian Indians, a high-risk group.
The aim of the study was to assess the association of hsCRP with T2D and to determine its correlates in North Indians of Indo-European origin.
A cross-sectional population-based study of 2520 urban subjects, comprising 1410 T2D patients and 1110 nondiabetic subjects, was carried out and 18 metabolic traits were assessed.
Median hsCRP levels were significantly higher in both diabetic men and women as compared to their nondiabetic counterparts (P < 0.0001). Elevated hsCRP was positively associated with T2D (odds ratio, 1.66; 95% confidence interval, 1.21-2.28; P = 0.002) even after adjusting for markers of obesity. After adjustments for age, sex, and BMI, HbA1c was the major correlate of hsCRP in nondiabetic subjects (beta = 0.28; P = 0.03). We observed that T2D patients were at higher risk for cardiovascular disease compared to nondiabetic subjects when classified into low-, intermediate-, and high-risk groups based on hsCRP levels (p(trend) = 3.8 x 10(-15)).
We demonstrate the association of low-grade systemic inflammation, as indicated by elevated hsCRP levels, with T2D in North Indian population. This association was independent of obesity. Obesity and glycemic control were the major correlates of hsCRP levels. Future studies are required to evaluate the influence of modulators including genetic variations on the elevation of hsCRP levels in this population.
高敏C反应蛋白(hsCRP)水平升高常被证明与2型糖尿病(T2D)相关;然而,对于亚洲印度人这一高危群体,对此了解甚少。
本研究旨在评估hsCRP与T2D的关联,并确定其在印欧血统的北印度人中的相关因素。
对2520名城市受试者进行了一项基于人群的横断面研究,其中包括1410名T2D患者和1110名非糖尿病受试者,并评估了18种代谢特征。
与非糖尿病男性和女性相比,糖尿病男性和女性的hsCRP中位数水平均显著更高(P < 0.0001)。即使在调整肥胖指标后,hsCRP升高仍与T2D呈正相关(优势比,1.66;95%置信区间,1.21 - 2.28;P = 0.002)。在调整年龄、性别和BMI后,HbA1c是非糖尿病受试者中hsCRP的主要相关因素(β = 0.28;P = 0.03)。当根据hsCRP水平分为低、中、高风险组时,我们观察到T2D患者患心血管疾病的风险高于非糖尿病受试者(P(趋势)= 3.8×10^(-15))。
我们证明了北印度人群中hsCRP水平升高所表明的低度全身炎症与T2D之间的关联。这种关联独立于肥胖。肥胖和血糖控制是hsCRP水平的主要相关因素。未来需要进行研究,以评估包括基因变异在内的调节因素对该人群hsCRP水平升高的影响。